Back

dr. J.A.N. (Jannick) Dorresteijn

Assistant Professor - medical
dr. J.A.N. (Jannick) Dorresteijn
  • Internal Medicine

Research Programs

Circulatory Health

Biography

Biography

Jannick Dorresteijn studied Medicine (2009) and Clinical Epidemiology (2011) at Utrecht University. His doctoral research focused on personalizing preventive treatment of cardiovascular disease based on statistical algorithms that support shared-decision making in the doctor’s office. He conducted this research partly at Harvard University. In 2013 this led to a promotion with honors (‘cum laude’) at Utrecht University. He trained as an Internist (2012-2019) at the Diakonessenhuis Utrecht and the University Medical Center Utrecht. In 2016 he received a Dekker grant from the Dutch Heart Foundation to continue his research. In 2018, this research resulted in the go-live of http://U-Prevent.com, a website that makes available statistical algorithms for personalization of preventive medication for cardiovascular diseases for use in clinical practice. From 2019-2020 he worked as an Internist-Specialist in Vascular Medicine at Rijnstate hospital in Arnhem and since 2020 at the University Medical Center Utrecht.

Research Output (49)

Prediction of individualized lifetime benefit from cholesterol lowering, blood pressure lowering, antithrombotic therapy, and smoking cessation in apparently healthy people

Jaspers Nicole E.M., Blaha Michael J., Matsushita Kunihiro, Van Der Schouw Yvonne T., Wareham Nicholas J., Khaw Kay Tee, Geisel Marie H., Lehmann Nils, Erbel Raimund, Jöckel Karl Heinz, Van Der Graaf Yolanda, Verschuren W. M.Monique, Boer Jolanda M.A., Nambi Vijay, Visseren Frank L.J., Dorresteijn Jannick A.N. 14 mrt 2020, In: European heart journal. 41 , p. 1190-1199 10 p.

Cardiovascular risk factors and the risk of major adverse limb events in patients with symptomatic cardiovascular disease

Hageman Steven H.J., De Borst Gert Jan, Dorresteijn Johannes A.N., Bots Michiel L., Westerink Jan, Asselbergs Folkert W., Visseren Frank L.J. 1 jan 2020, In: Heart. 106 , p. 1686-1692 7 p.

Treatment of hypercholesterolaemia in older adults calls for a patient-centred approach

Kleipool Emma E.F., Dorresteijn Johannes A.N., Smulders Yvo M., Visseren Frank L.J., Peters Mike J.L., Muller Majon 28 nov 2019, In: Heart. 106 , p. 261-266 6 p.

Heterogeneity of treatment effects from an intensive lifestyle weight loss intervention on cardiovascular events in patients with type 2 diabetes:Data from the look AHEAD trial

De Vries Tamar I., Dorresteijn Jannick A.N., Van Der Graaf Yolanda, Visseren Frank L.J., Westerink Jan 1 okt 2019, In: Diabetes Care. 42 , p. 1988-1994 7 p.

Risk prediction tools in cardiovascular disease prevention:A report from the ESC Prevention of CVD Programme led by the European Association of Preventive Cardiology (EAPC) in collaboration with the Acute Cardiovascular Care Association (ACCA) and the Association of Cardiovascular Nursing and Allied Professions (ACNAP)

Rossello Xavier, Dorresteijn Jannick A.N., Janssen Arne, Lambrinou Ekaterini, Scherrenberg Martijn, Bonnefoy-Cudraz Eric, Cobain Mark, Piepoli Massimo F., Visseren Frank L.J., Dendale Paul okt 2019, In: European Journal of Cardiovascular Nursing. 18 , p. 534-544 11 p.

Estimating individual lifetime benefit and bleeding risk of adding rivaroxaban to aspirin for patients with stable cardiovascular disease:results from the COMPASS trial

de Vries Tamar I., Eikelboom John W., Bosch Jackie, Westerink Jan, Dorresteijn Jannick A.N., Alings Marco, Dyal Leanne, Berkowitz Scott D., van der Graaf Yolanda, Fox Keith A.A., Visseren Frank L.J. 1 sep 2019, In: European Heart Journal. 40 , p. 3771-3778a

Risk prediction tools in cardiovascular disease prevention: A report from the ESC Prevention of CVD Programme led by the European Association of Preventive Cardiology (EAPC) in collaboration with the Acute Cardiovascular Care Association (ACCA) and the Association of Cardiovascular Nursing and Allied Professions (ACNAP)

Rossello Xavier, Dorresteijn Jannick A. N., Janssen Arne, Lambrinou Ekaterini, Scherrenberg Martijn, Bonnefoy-Cudraz Eric, Cobain Mark, Piepoli Massimo F., Visseren Frank L. J., Dendale Paul sep 2019, In: European Journal of Preventive Cardiology. 26 , p. 1534-1544 11 p.

Observational study of the medical management of patients with peripheral artery disease

Saratzis A., Jaspers N. E.M., Gwilym B., Thomas O., Tsui A., Lefroy R., Parks M., Htun V., Mera Z., Thatcher A., Bosanquet D., Forsythe R., Benson R., Dattani N., Dovell G., Lane T., Shalhoub J., Sidloff D., Visseren F. L.J., Dorresteijn J. A.N., Richards T., aug 2019, In: British Journal of Surgery. 106 , p. 1168-1177 10 p.

Risk prediction tools in cardiovascular disease prevention:A report from the ESC Prevention of CVD Programme led by the European Association of Preventive Cardiology (EAPC) in collaboration with the Acute Cardiovascular Care Association (ACCA) and the Association of Cardiovascular Nursing and Allied Professions (ACNAP)

Rossello Xavier, Dorresteijn Jannick An, Janssen Arne, Lambrinou Ekaterini, Scherrenberg Martijn, Bonnefoy-Cudraz Eric, Cobain Mark, Piepoli Massimo F, Visseren Frank Lj, Dendale Paul 25 jun 2019, In: European Heart Journal. Acute Cardiovascular Care. 9 , p. 522-532 11 p.

Individual Treatment Effect Estimation of 2 Doses of Dabigatran on Stroke and Major Bleeding in Atrial Fibrillation:Results from the RE-LY Trial

Stam-Slob Manon C, Connolly Stuart J, van der Graaf Yolanda, van der Leeuw Joep, Dorresteijn Jannick A N, Eikelboom John W, Peters Ron J G, Alings Marco, Visseren Frank L J 18 jun 2019, In: Circulation. 139 , p. 2846-2856 11 p.

All research output

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl maakt gebruik van cookies

Deze website maakt gebruik van cookies Deze website toont video’s van o.a. YouTube. Dergelijke partijen plaatsen cookies (third party cookies). Als u deze cookies niet wilt kunt u dat hier aangeven. Wij plaatsen zelf ook cookies om onze site te verbeteren.

Lees meer over het cookiebeleid

Akkoord Nee, liever niet